Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance.
- NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_assertion wasGeneratedBy ECO_0000203 NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance.
- NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_assertion wasDerivedFrom befree-20150227 NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance.
- NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_assertion SIO_000772 24588013 NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance.
- NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_assertion evidence source_evidence_literature NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance.
- NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_assertion description "[Drug targeting of fusion genes has proven to be an extremely effective therapeutic approach for cancers such as the recurrent BCR–ABL1 fusion in chronic myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265429.RAmSDwq2jBrBH41yWr5r5HocA3wfGi9cn9fNSup9sq7h4130_provenance.